NIH-funded research U01 cooperative agreement

Understanding how everyday exposures affect Alzheimer's disease progression

Official title: The Role of Chemical Exposures in Alzheimer's Disease (AD) and its Trajectory

Funded at University of Texas Hlth Sci Ctr Houston · NIH-11609305 · Data updated 2026-11-12

A national research effort is studying how environmental exposures, gut health, diet, and metabolism relate to Alzheimer's and related dementias to identify new ways to diagnose and treat these conditions.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Sci Ctr Houston
NIH-funded
Lab location1 site (Houston, United States)
Project startAugust 1, 2026
Project endJuly 31, 2029
Funding year2026
Award (this year)$81,000
NIH project number3U01AG088562-03S2
Project IDNIH-11609305 on NIH RePORTER

Who could benefit from this research

Could help

Individuals at various stages of Alzheimer’s disease or related dementias, and those who could contribute biological samples or imaging data.

Less likely to help

Participants with conditions outside the AD/ADRD spectrum or those unable to provide samples or imaging data may not directly benefit.

What this research studies

This project uses advanced metabolomics and lipidomics, along with genomic and brain imaging data, to map how exposures and biology interact across the Alzheimer’s disease spectrum. Conducted in collaboration with large networks, it builds a shared molecular atlas of AD that links the exposome to brain changes. The effort also investigates how the gut microbiome and lifestyle factors influence brain health and disease. The work aims to identify molecular patterns that could lead to better diagnostics and personalized treatment options for people living with AD or ADRD.

Why it matters

Potential benefit: If successful, this research could lead to earlier detection and more targeted therapies for Alzheimer’s disease and related dementias.

How similar studies have gone: Previous studies have linked metabolomic changes to brain imaging and cognitive decline, supporting the potential of this approach, though the integrated atlas is still being built.

Where this research is happening

  • University of Texas Hlth Sci Ctr Houston
    Houston, United States
    Active

Researchers

  • Principal investigator: Kaddurah-Daouk, Rima F — University of Texas Hlth Sci Ctr Houston
  • Study coordinator: Kaddurah-Daouk, Rima F

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.